The largest database of trusted experimental protocols

Mir nc

Manufactured by OriGene
Sourced in United States

The MiR-NC is a laboratory equipment product offered by OriGene. It serves as a negative control for miRNA experiments. The core function of the MiR-NC is to provide a reference sample for normalization and comparison in miRNA-related research applications.

Automatically generated - may contain errors

2 protocols using mir nc

1

Plasmid Extraction and Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The miR-376b and miR-376b-mimic expression plasmids and the negative control (miR-NC) were purchased from the Origene Company (Rockville, MD, USA). Plasmids were extracted using EndoFree Plasmid Giga kits (#12362; Qiagen GmbH, Hilden, Germany) from DH5α (Genewiz, Suzhou, China) Escherichia coli transformants and stored at −20°C until further use. The concentration was determined by measuring the A260/A280 ratio using an ND 2000 spectrophotometer (Thermo Fisher Scientific, Inc., Waltham, MA, USA).
+ Open protocol
+ Expand
2

miR-140-5p and STAT3 Overexpression in RA FLS

Check if the same lab product or an alternative is used in the 5 most similar protocols
miR-140-5p and miR-NC was obtained from Origene Technologies, Inc. The mature-miR-140-5p and miR-NC sequence was cloned into pCDHCMV-MCS-EF1-coGFP constructs (Invitrogen; Thermo Fisher Scientific, Inc.). For STAT3 overexpression, the coding sequences of STAT3 were amplified from cDNA isolated from RA FLS using a PCR kit (AP111-11; TransGen Biotech Co., Ltd.). The thermocycling conditions were as follows: 95˚C for 10 min, followed by 40 cycles of 95˚C for 15 sec, 60˚C for 30 sec and 72˚C for 30 sec. Sequences for primers were as follows: STAT3 forward, 5'-GACTTAGTCCCAGGTACT-3' and reverse, TTCAACTGACCTAGGACGTGGTCG-3'. The product was inserted into the pcDNA3.1 vector (Invitrogen; Thermo Fisher Scientific, Inc.) to generate STAT3 expression vectors pcDNA3.1-SOX11. Cells were transfected with pCDHCMV-MCS-EF1-coGFP-miR-140-5p and/or pcDNA3.1-SOX11 using Lipofectamine® RNAiMAX/2000 transfection reagent (Invitrogen; Thermo Fisher Scientific, Inc.) and then collected at 48 h after transfection. All constructions were confirmed using plasmid DNA sequencing using the dideoxy chain-termination (Sanger) method with Applied Biosystems 3730XL (Genescript).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!